3 April 2020 in Frontiers in Pharmacology
Disruption in cholesterol metabolism, particularly hypercholesterolemia, is a significant cause of atherosclerotic cardiovascular disease. Large interindividual variations in plasma cholesterol levels are traditionally related to genetic factors, and the remaining portion of their variance is accredited to environmental factors. In recent years, the essential role played by intestinal microbiota in human health and diseases has emerged. The gut microbiota is currently viewed as a fundamental regulator of host metabolism and of innate and adaptive immunity. Its bacterial composition but also the synthesis of multiple molecules resulting from bacterial metabolism vary according to diet, antibiotics, drugs used, and exposure to pollutants and infectious agents. Microbiota modifications induced by recent changes in the human environment thus seem to be a major factor in the current epidemic of metabolic/inflammatory diseases (diabetes mellitus, liver diseases, inflammatory bowel disease, obesity, and dyslipidemia). Epidemiological and preclinical studies report associations between bacterial communities and cholesterolemia. However, such an association remains poorly investigated and characterized. The objectives of this review are to present the current knowledge on and potential mechanisms underlying the host-microbiota dialogue for a better understanding of the contribution of microbial communities to the regulation of cholesterol homeostasis.
3 October 2025 in Science Advances
Foxp3 + regulatory T cells (T regs ) reside in both lymphoid and nonlymphoid organs, where they play a crucial role in immune tolerance and tissue homeostasis. In mice, T regs begin colonizing these tissues shortly after birth, contributing to long-term immune response regulation therein. However, the kinetics of T reg generation across different tissues remains unclear. Here, we investigate T reg ontogeny from birth to adulthood in various tissues. In lymphoid organs, the adult T reg pool is continuously replenished with cells generated at different ages. In contrast, the skin retains a large fraction of T regs that colonize the tissue during the neonatal period, with minimal turnover in adulthood. The liver, lungs, and colon exhibit intermediate T reg renewal dynamics. Notably, neonatal T regs that persist into adulthood display a more activated phenotype and express markers associated with tissue-resident T regs and type 2 immunity. Our findings reveal tissue-specific differences in T reg generation kinetics and highlight a major phenotypic shift between neonatal and adult-derived T regs .
17 December 2024 in bioRxiv
Summary: Parkinson’s disease (PD) is associated with gut microbiome shifts, but the functional consequences remain unclear. Here, we use an integrated multi-omics approach to compare the gut microbiomes of individuals with PD and prodromal PD as well as healthy individuals. After analyzing each omics, meta-metabolomic was selected to inform the analysis as it represents the most discriminatory and robust ome. We identified 11 metabolites that were differentially abundant between the groups, amongst which β-glutamate was increased in PD and prodromal PD, and correlated with the transcriptional activities of Methanobrevibacter smithii and Clostridium spp. We identified decreases in transcripts, but not in gene abundances, related to glutamate metabolism, bile acids, chemotaxis and flagellar assembly in PD, particularly in keystone genera such as Roseburia, Agathobacter and Blautia . Our findings, integrated into the Expobiome map, reveal multifactorial microbiome alterations which converge with PD pathways. Our study highlights the importance of investigating the gut microbiome’s functional dimensions to better resolve microbiome-host interactions in health and disease.
30 December 2024 in bioRxiv
Alterations of gut microbiome structure have been observed in a panoply of human diseases including neurodegeneration. However, the ecological and functional deficits of microbiome dysbiosis have yet to be understood. Here, using integrated multi-omics (metagenomics and metatranscriptomics), we resolve microbiome gene co-expression networks in individuals with Parkinson′s disease (PD) and healthy individuals. We uncover network modules with high closeness and degree centrality that represent core ecological functions, and identify key features lost in PD. More specifically, we observe a significant depletion in specific functions including secondary bile acid biosynthesis and flagellar assembly (FA) in PD. Strikingly, most hub genes, particularly those involved in bacterial microcompartments (BMCs) and FA, are predominantly found in healthy individuals. Blautia and Anaerobutyricum genera are the main contributors to these functions, showing significantly lower expression of BMC genes in PD. Additionally, we identify a strong correlation between the expression of BMC and FA genes, but also an apparent dysregulation in cross feeding between commensals in PD. Importantly, gene expression in PD was tied to reduced diversity in expressed genes, whereas in healthy individuals, higher expression levels were linked to higher diversity. Our findings reveal disruptions in key gut metabolic functions at both functional and taxonomic levels, potentially driving disease progression. Notably, we identify crucial microbiome-wide ecological features that should be restored in future gut microbiome rewilding efforts.